CM
Castleark Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-98,850
| Closed | -$8.9M | – | 348 |
|
|
2024
Q4 | $8.9M | Sell |
98,850
-16,730
| -14% | -$1.51M | 0.31% | 53 |
|
|
2024
Q3 | $11.4M | Buy |
115,580
+65,490
| +131% | +$6.47M | 0.47% | 37 |
|
|
2024
Q2 | $4.64M | Sell |
50,090
-50,090
| -50% | -$4.64M | 0.19% | 120 |
|
|
2024
Q1 | $9.51M | Buy |
+100,180
| New | +$9.51M | 0.4% | 46 |
|
|
2023
Q3 | – | Sell |
-143,110
| Closed | -$11.9M | – | 320 |
|
|
2023
Q2 | $11.9M | Buy |
+143,110
| New | +$11.9M | 0.54% | 33 |
|
|
2023
Q1 | – | Sell |
-448,640
| Closed | -$37.2M | – | 326 |
|
|
2022
Q4 | $37.2M | Hold |
448,640
| – | – | 1.95% | 13 |
|
|
2022
Q3 | $35.6M | Sell |
448,640
-195,250
| -30% | -$15.5M | 1.98% | 11 |
|
|
2022
Q2 | $47.8M | Buy |
+643,890
| New | +$47.8M | 2.56% | 8 |
|
|
2014
Q1 | – | Sell |
-6,400
| Closed | -$833K | – | 334 |
|
|
2013
Q4 | $833K | Buy |
6,400
+490
| +8% | +$63.8K | 0.02% | 252 |
|
|
2013
Q3 | $922K | Buy |
5,910
+4,710
| +393% | +$735K | 0.03% | 247 |
|
|
2013
Q2 | $125K | Buy |
+1,200
| New | +$125K | ﹤0.01% | 291 |
|